Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Ocado, Abcam

Tue, 20th Jun 2023 08:22

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p and placed the stock on 'negative catalyst watch' into first-half results.

JPM said: "We believe Ocado's online grocery activities will continue to face meaningful headwinds in the next months."

The bank, which rates Ocado at 'underweight', said the latest Kantar data suggest ongoing market share gains for offline discounters given the current macro backdrop/falling consumer budgets.

It also noted that higher, inflation-driven average selling prices are almost fully offset by lower basket sizes, while cost inflation - wages but also electricity, icing etc - is negatively impacting UK Retail's bottom line.

JPM said it sees downside to consensus FY23 estimates.

"With Ocado's UK Retail operations barely profitable in 2023, we see limited scope for Retail to act as the required showcase for the company's Solutions operation," it said.

It also said it's "becoming clearer" that the shift towards more customer fulfilment centres (CFCs) is likely to remain slow for supermarkets as in-store picking solutions seem currently to be the preferred choice to better monetise the established branch network and limit capex.

JPM said that despite Ocado's recent share price weakness - the shares are down 30% year-to-date and 44% in the last 12 months - the current share price levels still reflect an additional 54 CFCs to be announced.

"With (a lack of) new partnership announcements likely to remain the key share price driver from here, we see risk-reward still as unattractive versus other names in the EU Internet sector and remain UW."

RBC Capital Markets downgraded Abcam to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as it recommended investors take profit on bid anticipation.

It noted that the shares are up 40% in the last 10 days, and 65% in the quarter to date.

"It is unclear how advanced the 'strategic inquiries' are, and the valuation work in this report implies relatively little further upside on a transaction anyway," RBC said.

"We have always liked Abcam's fundamentals but see activist investor engagement and anticipation of a potential bid as likely to drive material volatility in the shares.

"While our $22 price target informs our downgrade to sector perform, we would take profits here."

More News
27 Oct 2021 08:48

Abcam completes earnings-accretive BioVision acquisition

(Sharecast News) - Science research tools company Abcam announced on Wednesday that it has completed its acquisition of BioVision from Boai NKY Medical Holdings, for total consideration of $340m.

Read more
30 Sep 2021 09:35

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

Read more
15 Sep 2021 09:39

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

Read more
13 Sep 2021 13:01

IN BRIEF: Abcam profit grows as lab activity and demand recover

IN BRIEF: Abcam profit grows as lab activity and demand recover

Read more
6 Sep 2021 15:58

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 16:22

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

PRESS: IP Group's Oxford Nanopore set for London float soon - Reuters

Read more
13 Aug 2021 14:45

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Read more
2 Aug 2021 09:48

Abcam to buy BioVision for $340m

(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m.

Read more
2 Aug 2021 08:55

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Read more
2 Aug 2021 07:43

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

LONDON MARKET PRE-OPEN: Meggitt agrees to GBP6.3 billion takeover

Read more
1 Jul 2021 13:17

Abcam trades in line with expectations as lab product demand limited

Abcam trades in line with expectations as lab product demand limited

Read more
24 Jun 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
24 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
23 Jun 2021 09:31

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

BROKER RATINGS: HSBC cuts Burberry; Deutsche raises Travis Perkins

Read more
2 Jun 2021 10:54

Abcam confirms financial year-end date change to December 31

Abcam confirms financial year-end date change to December 31

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.